CNO CNO Financial Group, Inc. Insider Trading

CNO Financial President Scott L. Goldberg sold 22,120 shares for $879,423.73 on 2026-03-19/20 at $39.76 avg; now holds 214,524 shares

Scott L. Goldberg, President of the Consumer Division, executed 2 separate sales totaling 22,120 shares for $879,423.73 between March 19–20, 2026, reducing his stake by 9.3% to 214,524 shares. His cross-ticker track record shows a 100.00% well-timed rate on 2 prior sells with average 90-day returns of -5.7%, and at CNO specifically, both prior sales (March 2025) posted negative 90-day returns of -8.0% and -5.9% respectively. The current price of $40.54 lies 9.2% below the 52-week high of $44.64 and down 6.2% over 30 days, consistent with downward momentum. Given CNO's elevated P/E of 29.81, modest revenue growth of +0.8%, and a net income of only $23.1M against $1.2B revenue, the financial profile suggests limited margin of safety at current valuations—a backdrop against which a pattern of well-timed sells by a senior operator warrants investor attention.

CNO General Counsel Matthew J. Zimpfer sold 57,370 shares for $2,472,553.89 at average $43.10 on Feb 17–18.

Zimpfer executed 2 separate sales totaling 57,370 shares for $2,472,553.89, reducing his holdings from 365,307 shares to 307,937 shares (-15.7%). This represents his third open-market sale at CNO within a month—he sold again on 2026-02-12, just five days prior. His prior 2 measurable sales at CNO occurred on 2025-02-19 and 2025-02-21; both showed negative 90-day returns of -1.2% and -7.1% respectively, meaning he sold before subsequent declines. At the cross-ticker level, his track record across 3 prior sales shows a 100.00% well-timed rate at the 90-day mark. The current stock price of $43.04 sits near the blended sale price of $43.10, placing it near 52-week highs and +8.2% over 90 days. The timing of consecutive sales within days, combined with his prior pattern of selling before downturns at this ticker, may warrant observation of subsequent price action.

CNO CEO Bhojwani sold 88,378 shares for $3.8M across two days (Feb 17-18, 2026), reducing holdings 24.2%.

Bhojwani Gary C., CEO of CNO Financial Group, executed 2 separate sales totaling 88,378 shares for $3,809,968.02 on February 17-18, 2026, at prices of $43.17 and $43.05 respectively. This represents a -24.2% reduction in his post-transaction holdings to 277,526 shares. The sales occurred near the stock's 52-week high ($44.64), with the current price at $43.04. His same-ticker history at CNO shows 3 of 4 prior measurable sells were well-timed at the 90-day mark, suggesting a pattern of selling into strength; however, the most recent prior CNO sale on 2026-01-02 has not yet accumulated sufficient time for outcome measurement. The company's fundamentals remain solid with $1.2B in quarterly revenue, P/E of 13.58, and annual revenue growth of +7.3%, providing limited fundamental distress signals. This transaction warrants monitoring to determine whether it reflects a continuation of prior tactical selling patterns or a shift in insider conviction toward the position.

CNO General Counsel Zimpfer sells 30,970 shares at $42.93; prior two CNO sells both delivered negative 90-day returns.

Matthew J. Zimpfer, General Counsel of CNO Financial Group, sold 30,970 shares (31.0K shares) on 2026-02-12 at $42.93, reducing holdings by 9.1% to 307.9K shares. His prior two open-market sales at CNO (on 2025-02-21 and 2025-02-19) both posted negative 90-day returns (-7.1% and -5.4%), establishing a 2-of-2 pattern of well-timed exits. At the current price of $43.20, the stock trades 3.2% below its 52-week high and 4.8% above its 90-day level, suggesting modest upside momentum into early February. The company's fundamentals remain solid with 7.3% annual revenue growth and a P/E of 13.63, but Zimpfer's consistent prior timing of sales before CNO declines deserves attention as a potential leading indicator of near-term weakness.

CNO Financial CEO Bhojwani sells 31,430 shares for $1.3M; stock up 6.6% over 90 days, prior 4-for-4 sells at CNO well-timed with negative returns after each.

CEO Gary C. Bhojwani sold 31,430 shares at $41.99 on 2026-01-02, reducing his holdings by 13.8% to 195,926 shares post-transaction. His prior four measurable sales at CNO (from March through early April 2025) were consistently well-timed at the 90-day mark, with outcomes of -9.3%, -6.7%, -6.7%, and -5.7% respectively, indicating the stock declined after each sale. This transaction arrives as the stock is trading at $42.20, up 6.6% over 90 days and 4.1% over 30 days—a period when the stock has recovered from its recent weakness. The established pattern of disciplined, well-timed exits at this specific ticker warrants attention, though the current price strength since the sale execution differs from the downside outcomes that followed his prior four transactions at CNO.

CEO Gary C. Bhojwani sold 31,430 shares of CNO at $39.97; prior trades at ticker show 5 of 5 well-timed 90-day outcomes.

Bhojwani sold 31,430 shares (31.4K shares) for $1,256,341.96 ($1.3M), reducing his holdings by 12.1% from 258,786 to 227,356 shares. His prior five sales at CNO all registered negative 90-day returns ranging from -4.9% to -10.1%, with 5 of 5 sales well-timed at the 90-day mark. His cross-ticker track record shows 9 prior sells with a 77.78% well-timed rate and average 90-day return of -4.1%, indicating a consistent pattern of selling ahead of downturns. CNO trades at a P/E of 12.76 with $1.2B quarterly revenue and $23.1M net income; the stock is -4.5% from its 52-week high of $42.37 and currently at $40.45. The timing pattern—a perfect 5 of 5 well-timed sales at this ticker—merits monitoring for whether this sale proves similarly prescient in the 90-day window ahead.

CNO CIO Eric R. Johnson sold 48,665 shares at $41.24 for $2.0M, reducing stake 6.8% to 671.5K shares.

Johnson Eric R., Chief Investment Officer of CNO Financial Group, sold 48,665 shares at $41.24 on 2025-11-10, generating $2,007,012.73 in proceeds and reducing his holdings from 720,207 shares to 671,542 shares. The sale occurred near the 52-week high of $42.37, with the stock currently at $41.41. His cross-ticker track record shows 1 prior open-market sell with an average 90-day return of +3.5%, meaning his past sales were followed by stock gains rather than declines—a poorly-timed pattern overall. At the same ticker (CNO), his prior sell on 2024-11-12 also saw the stock rise +3.5% over 90 days, further indicating no pattern of well-timed exits at this company. The transaction itself represents a routine modest reduction in an already substantial long position.

CNO Financial President DeToro Karen J. sells 25,657 shares ($973.0K) across 3 trades; post-sale holdings 41,855 shares (-38.0%)

Karen J. DeToro, President of the Worksite Division at CNO Financial Group, executed 3 separate sales totaling 25,657 shares over three consecutive trading days (August 13–15, 2025) at a blended average price of $37.92, generating proceeds of $973,017.58. This represents a 38.0% reduction in her pre-transaction holdings from 67,512 shares to 41,855 shares. The current stock price of $37.62 sits approximately 11.2% below the 52-week high of $42.37, while the company trades at a P/E of 12.62 with recent quarterly revenue of $1,151,500,000 and annual revenue growth of 7.3%. The magnitude of this multi-day divestiture—representing over one-third of her equity stake—merits investor attention to determine whether the sales reflect portfolio management, liquidity needs, or other considerations.

CNO CIO Mead sells 24,970 shares (61.4% of holdings) in 2 transactions for $950.9K at $38.08 avg; retains 15.7K shares

Mead Michael E., CNO's Chief Information Officer, executed 2 separate sales totaling 24,970 shares for $950,902.53, reducing his holdings by 61.4% from 40,699 shares to 15,729 shares. The sales occurred on 2025-07-03 at $38.20 and 2025-07-07 at $37.97, with a blended average of $38.08—a modest premium to the current price of $37.49 and just below the 52-week high of $42.37. While the company shows stable fundamentals (P/E of 12.17, revenue growth of 7.3% YoY, and a $3.7B market cap), the material reduction in insider holdings—from 40.7K to 15.7K shares—warrants attention. The lack of offsetting transactions or accumulation activity in the filing suggests this represents a substantial net portfolio reduction rather than a routine rebalancing event.

CNO Financial CEO Gary Bhojwani sold 53,912 shares over 3 days for $2,211,673.57; holdings reduced 21.0% to 202.7K shares

Gary Bhojwani, Chief Executive Officer of CNO Financial Group, executed 3 separate sales totaling 53,912 shares for $2,211,673.57 at a blended average price of $41.02. This sale reduced his holdings by 21.0% from 256.6K to 202.7K shares. The transaction occurred while the stock traded near the high end of its 52-week range ($25.12–$42.37), with current price at $39.56 representing a -6.6% distance from the 52-week high. At the same ticker, Bhojwani's prior 3 measurable sales (2024) showed 2 of 3 were well-timed at the 90-day mark, suggesting a historical pattern of selling before declines at this company. The blended sale price of $41.02 sits materially above the current price, positioning this sale favorably in hindsight, though the magnitude of the position reduction during a valuation window close to peaks warrants observation of post-sale price action.